ERBB3 and breast cancer: To understand the underly mechanism of HER3 upregulation post-panobinostat treatment in CL TNBC cells, we thoroughly reviewed the literature and found that c-Myc had been implicated in the adaptive reprogramming of breast cancer kinome.